Consolidated Financial Statements for the Third Quarter Ended December 31, 2019 FY2020 (April 1, 2019 – March 31, 2020)[UNAUDITED] February 13, 2020February 13, 2020 by / Share This.....LinkedinTwitterFacebookGoogleEmail About Us Message from the president Corporate Data and Subsidiaries Corporate Executives Directions to Takara Bio Quality Assurance Policy Consolidated Subsidiaries Business Outline Bioindustry Gene Therapy News Release Investor Relstions Management Policy Financial Data IR Library Stock Information IR Calendar IR News Disclosure Policy FAQ Contact IR User Guide Products Site About Us Business Outline News Release Investor Relstions Japanese Products Site サブ-ナビゲーション Top Management Policy Message from the President Formulation of Medium-Term Management Plan FY2020 Corporate Governance Business Risks Financial Data Financial Highlights Financial Indicators Cash Flow Business Segments IR Library Financial Results Presentation Materials Annual Report Stock Information General Meeting of Shareholders Shareholder Return / Dividends Stock Overview Stock Status Stock Price IR Calendar IR News Disclosure Policy FAQ Contact IR User Guide 2020/02/13 Related News: Consolidated Financial Statements for the Third…Consolidated Financial Statements for the Year Ended…Consolidated Financial Statements for the Second…Consolidated Financial Results for the Nine Months…Consolidated Financial Results for the Fiscal Year…Consolidated Financial Results for the Three Months…
